[HTML][HTML] Adalimumab in Pediatric Inflammatory Bowel Disease
SY Choi, B Kang - Frontiers in Pediatrics, 2022 - frontiersin.org
The introduction of biological agents with strong anti-inflammatory action, such as antitumor
necrosis factor (TNF) agents, has changed inflammatory bowel disease (IBD) treatment …
necrosis factor (TNF) agents, has changed inflammatory bowel disease (IBD) treatment …
Adalimumab in Pediatric Inflammatory Bowel Disease
SY Choi, B Kang - Frontiers in pediatrics, 2022 - pubmed.ncbi.nlm.nih.gov
The introduction of biological agents with strong anti-inflammatory action, such as antitumor
necrosis factor (TNF) agents, has changed inflammatory bowel disease (IBD) treatment …
necrosis factor (TNF) agents, has changed inflammatory bowel disease (IBD) treatment …
[HTML][HTML] Adalimumab in Pediatric Inflammatory Bowel Disease
SY Choi, B Kang - Frontiers in Pediatrics, 2022 - ncbi.nlm.nih.gov
The introduction of biological agents with strong anti-inflammatory action, such as antitumor
necrosis factor (TNF) agents, has changed inflammatory bowel disease (IBD) treatment …
necrosis factor (TNF) agents, has changed inflammatory bowel disease (IBD) treatment …
Adalimumab in Pediatric Inflammatory Bowel Disease.
SY Choi, B Kang - Frontiers in Pediatrics, 2022 - europepmc.org
The introduction of biological agents with strong anti-inflammatory action, such as antitumor
necrosis factor (TNF) agents, has changed inflammatory bowel disease (IBD) treatment …
necrosis factor (TNF) agents, has changed inflammatory bowel disease (IBD) treatment …